PNC Financial Services Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247K | Buy |
16,960
+1,373
| +9% | +$13.2K | ﹤0.01% | 2306 |
|
|
2026
Q1 | $116K | Sell |
15,587
-889
| -5% | -$9.35K | ﹤0.01% | 2711 |
|
|
2025
Q4 | $194K | Sell |
16,476
-1,619
| -9% | -$17.5K | ﹤0.01% | 2336 |
|
|
2025
Q3 | $140K | Buy |
18,095
+2,565
| +17% | +$18K | ﹤0.01% | 2558 |
|
|
2025
Q2 | $114K | Buy |
15,530
+11,175
| +257% | +$90.2K | ﹤0.01% | 2625 |
|
|
2025
Q1 | $41.3K | Sell |
4,355
-11,255
| -72% | -$141K | ﹤0.01% | 3204 |
|
|
2024
Q4 | $257K | Buy |
15,610
+770
| +5% | +$12K | ﹤0.01% | 2019 |
|
|
2024
Q3 | $219K | Sell |
14,840
-1,100
| -7% | -$17.2K | ﹤0.01% | 2118 |
|
|
2024
Q2 | $221K | Sell |
15,940
-4,603
| -22% | -$65.3K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $323K | Buy |
20,543
+12,109
| +144% | +$187K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $136K | Buy |
8,434
+1,791
| +27% | +$29.3K | ﹤0.01% | 2411 |
|
|
2023
Q3 | $81.7K | Sell |
6,643
-904
| -12% | -$13.4K | ﹤0.01% | 2694 |
|
|
2023
Q2 | $121K | Sell |
7,547
-892
| -11% | -$14.7K | ﹤0.01% | 2523 |
|
|
2023
Q1 | $147K | Buy |
8,439
+613
| +8% | +$8.73K | ﹤0.01% | 2336 |
|
|
2022
Q4 | $72.3K | Sell |
7,826
-9,084
| -54% | -$84.7K | ﹤0.01% | 2771 |
|
|
2022
Q3 | $145K | Buy |
16,910
+6,057
| +56% | +$60.2K | ﹤0.01% | 2302 |
|
|
2022
Q2 | $88K | Sell |
10,853
-7,904
| -42% | -$75.5K | ﹤0.01% | 2662 |
|
|
2022
Q1 | $228K | Sell |
18,757
-7,332
| -28% | -$154K | ﹤0.01% | 2169 |
|
|
2021
Q4 | $890K | Sell |
26,089
-2,089
| -7% | -$81.8K | ﹤0.01% | 1354 |
|
|
2021
Q3 | $1.36M | Buy |
28,178
+1,910
| +7% | +$88.4K | ﹤0.01% | 1048 |
|
|
2021
Q2 | $1.19M | Buy |
26,268
+126
| +0.5% | +$5.58K | ﹤0.01% | 1126 |
|
|
2021
Q1 | $1.26M | Sell |
26,142
-1,314
| -5% | -$68.4K | ﹤0.01% | 1066 |
|
|
2020
Q4 | $1.48M | Sell |
27,456
-9,536
| -26% | -$431K | ﹤0.01% | 968 |
|
|
2020
Q3 | $1.36M | Buy |
36,992
+1,636
| +5% | +$60.8K | ﹤0.01% | 924 |
|
|
2020
Q2 | $1.1M | Buy |
35,356
+9,336
| +36% | +$259K | ﹤0.01% | 993 |
|
|
2020
Q1 | $718K | Sell |
26,020
-1,304
| -5% | -$39.1K | ﹤0.01% | 1115 |
|
|
2019
Q4 | $799K | Buy |
27,324
+9,584
| +54% | +$228K | ﹤0.01% | 1194 |
|
|
2019
Q3 | $340K | Sell |
17,740
-18,773
| -51% | -$440K | ﹤0.01% | 1820 |
|
|
2019
Q2 | $800K | Sell |
36,513
-928
| -2% | -$20.4K | ﹤0.01% | 1375 |
|
|
2019
Q1 | $766K | Buy |
37,441
+4,489
| +14% | +$78K | ﹤0.01% | 1415 |
|
|
2018
Q4 | $416K | Sell |
32,952
-20,000
| -38% | -$298K | ﹤0.01% | 1646 |
|
|
2018
Q3 | $813K | Buy |
52,952
+32,200
| +155% | +$445K | ﹤0.01% | 1436 |
|
|
2018
Q2 | $272K | Buy |
+20,752
| New | +$228K | ﹤0.01% | 2007 |
|
|
2016
Q3 | – | Sell |
-387
| Closed | -$3K | – | 4173 |
|
|
2016
Q2 | $3K | Sell |
387
-15
| -4% | -$120 | ﹤0.01% | 4045 |
|
|
2016
Q1 | $3K | Buy |
402
+14
| +4% | +$92 | ﹤0.01% | 4057 |
|
|
2015
Q4 | $3K | Buy |
+388
| New | +$2.84K | ﹤0.01% | 4048 |
|
|
2014
Q4 | – | Sell |
-300
| Closed | -$2K | – | 4221 |
|
|
2014
Q3 | $2K | Buy |
+300
| New | +$1.54K | ﹤0.01% | 3674 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
PNC Financial Services Group's NEO Position: Q2 2026 in Review
PNC Financial Services Group increased its NeoGenomics (NEO) stake by 8.8% in Q2 2026, buying an estimated $13.2K and bringing the position to 16,960 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.
PNC Financial Services Group first reported a position in NEO in Q3 2014 and has held it in 37 quarters since. The position peaked at $1.48M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- PNC Financial Services Group held 16,960 shares of NeoGenomics worth $247K as of Q2 2026.
- PNC Financial Services Group bought 1,373 NeoGenomics shares in Q2 2026, an estimated $13.2K.
- NeoGenomics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2306 holding.
- PNC Financial Services Group first reported a position in NeoGenomics in Q3 2014 and has held it in 37 quarters since.
- PNC Financial Services Group's NeoGenomics position peaked at $1.48M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.